<unk>  is a antineoplastic agent that is FDA approved for the treatment of non-squamous non-small cell lung cancer, mesothelioma.   Common adverse reactions include itching, peeling of skin, constipation, diarrhea, loss of appetite, nausea, pharyngitis, stomatitis, vomiting, anemia, leukopenia, neutropenia, thrombocytopenia, fatigue.
Pemetrexed
Taxane
Nilotinib
Epirubicin hydrochloride
Gemcitabine
Epirubicin
Ifosfamide
Mafosfamide